Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMFI
2076
DELISTED
Aetherium Acquisition Corp
GMFI
| $2.44M | ﹤0.01% |
240,015
| – | – |
|
2077
Exponent
EXPO
$3.24B
| $2.44M | ﹤0.01% |
24,613
-1,897
| -7% | -$184K |
|
2078
PUT
Virgin Galactic
SPCE
$398M
| $2.44M | ﹤0.01% |
+35,000
| New | +$3.27M |
|
2079
Macerich
MAC
$6.92B
| $2.44M | ﹤0.01% |
216,320
+84,351
| +64% | +$952K |
|
2080
Sunstone Hotel Investors
SHO
$2.06B
| $2.43M | ﹤0.01% |
251,822
+49,135
| +24% | +$508K |
|
2081
uniQure
QURE
$3.22B
| $2.43M | ﹤0.01% |
107,045
-31,745
| -23% | -$685K |
|
|
BIG
2082
DELISTED
Big Lots, Inc.
BIG
| $2.42M | ﹤0.01% |
164,879
+87,912
| +114% | +$1.51M |
|
2083
PUT
CVS Health
CVS
$122B
| $2.42M | ﹤0.01% |
+26,000
| New | +$2.51M |
|
2084
First Interstate BancSystem
FIBK
$3.58B
| $2.41M | ﹤0.01% |
62,405
+45,388
| +267% | +$1.92M |
|
2085
Cal-Maine
CALM
$3.99B
| $2.41M | ﹤0.01% |
44,236
+29,605
| +202% | +$1.71M |
|
2086
Transocean
RIG
$5.82B
| $2.4M | ﹤0.01% |
526,723
-75,600
| -13% | -$292K |
|
2087
TriNet
TNET
$3.14B
| $2.39M | ﹤0.01% |
35,290
-155,746
| -82% | -$10.7M |
|
2088
Fabrinet
FN
$20.1B
| $2.39M | ﹤0.01% |
18,637
+8,013
| +75% | +$956K |
|
2089
PUT
Automatic Data Processing
ADP
$108B
| $2.39M | ﹤0.01% |
+10,000
| New | +$2.46M |
|
2090
Thor Industries
THO
$4.14B
| $2.38M | ﹤0.01% |
31,593
-156,720
| -83% | -$12.6M |
|
2091
Dillards
DDS
$9.56B
| $2.38M | ﹤0.01% |
7,375
-6,468
| -47% | -$2.11M |
|
2092
Comfort Systems
FIX
$59.6B
| $2.38M | ﹤0.01% |
20,710
+4,136
| +25% | +$481K |
|
|
MOMO
2093
Hello Group
MOMO
$866M
| $2.38M | ﹤0.01% |
265,002
+243,130
| +1,112% | +$1.44M |
|
2094
California Resources
CRC
$4.62B
| $2.37M | ﹤0.01% |
54,440
+19,588
| +56% | +$858K |
|
2095
Coherus Oncology
CHRS
$196M
| $2.37M | ﹤0.01% |
299,006
+94,202
| +46% | +$725K |
|
2096
Power Integrations
POWI
$3.6B
| $2.37M | ﹤0.01% |
33,015
+8,238
| +33% | +$588K |
|
2097
Enanta Pharmaceuticals
ENTA
$400M
| $2.37M | ﹤0.01% |
50,899
+5,531
| +12% | +$252K |
|
2098
Xencor
XNCR
$1.55B
| $2.37M | ﹤0.01% |
90,857
+4,977
| +6% | +$139K |
|
2099
PUT
Darden Restaurants
DRI
$24.4B
| $2.37M | ﹤0.01% |
+17,100
| New | +$2.39M |
|
2100
Novanta
NOVT
$5.92B
| $2.37M | ﹤0.01% |
17,409
+10,318
| +146% | +$1.44M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.